-
<![CDATA[Amtagvi Prompts Responses in Non–Small Cell Lung Cancer]]>
06 Nov 2025 20:31 GMT
… non-squamous non-small cell lung cancer without actionable genetic mutations, new … non-squamous non-small cell lung cancer and a potential launch in … durability — with standard-of-care docetaxel monotherapy showing an ORR of …
-
Patients with Advanced Non-Small Cell Lung Cancer and the EGFR Exon 19 Deletion p.L747 Benefit from Chemotherapy and First-Generation Tyrosine Kinase Inhibitors Compared with Patients with p.E746
06 Nov 2025 14:10 GMT
… docetaxel in patients with non-small-cell lung cancer … mutant non-small cell lung cancer. Lung Cancer. 2014;86(2 … EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer. 2017 … advanced non-small-cell lung cancer. Lung Cancer. 2022;166:9– …
-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
03 Nov 2025 12:00 GMT
… durability. Standard-of-care docetaxel monotherapy in patients with … About Non-Small Cell Lung Cancer
Lung cancer is the most commonly … ,4 Approximately 85% of lung cancer cases are NSCLC, with … our non-small cell lung cancer clinical trials) and our …
-
The Value of Dynamic of Alkaline Phosphatase and Neutrophil-to-Lymphocyte Ratio in Predicting the Efficacy of Neoadjuvant Immunochemotherapy in Patients with Non-Small Cell Lung Cancer
25 Oct 2025 08:42 GMT
… docetaxel in patients with previously treated non-small-cell lung cancer … cell lung cancer patients treated with nivolumab. Lung Cancer. … -Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy … Assessment of Lung Cancer Resection Specimens …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … lung cancer.
Current treatment modalities for lung cancer … -NPs inhibited lung tumor growth by … docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer …
-
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
22 Oct 2025 16:12 GMT
… 80%-85% of all lung cancers, and most patients have … Daraxonrasib (RMC-6236) vs. Docetaxel in RAS-Mutant NSCLC”
… Cancer Institute. Non-Small Cell Lung Cancer Treatment. Available at: https … Society. Key Statistics for Lung Cancer. Available at: https:…
-
<![CDATA[Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy]]>
19 Oct 2025 18:00 GMT
… biomarkers in lung cancer.
Biomarkers in Lung Cancer
Lung cancer is the … for lung cancer and selecting patients for lung cancer therapy,” … 15% to 16% of lung cancers, representing a promising … versus docetaxel in previously treated non-small cell lung cancer. …
-
<![CDATA[From Mutation to Medicine: Targeted Therapies in Lung Cancer]]>
18 Oct 2025 21:25 GMT
… 1% to 4% of lung cancers, most often in … demonstrated improvements compared with docetaxel, outcomes underscore the … Unresectable Non-small Cell Lung Cancer (LAURA) (LAURA). … receptor non-small cell lung cancer (FLAURA2) (FLAURA2). Clinicaltrials …
-
<![CDATA[Dr Perol on Unmet Need for Post Immunotherapy Strategies in Lung Cancer]]>
16 Oct 2025 19:50 GMT
… , which is still docetaxel or docetaxel plus anti-angiogenic drugs … in non–small cell lung cancer (NSCLC).
This topic … Bridging the Gaps in Lung Cancer consensus meeting.
Perol noted … based regimens remains either docetaxel or docetaxel combined with anti- …
-
‘In EGFR-mutated lung cancer treatment, combo therapy emerges as new standard’
14 Oct 2025 07:23 GMT
… 2025 Asia Conference on Lung Cancer (ACLC25), held in … Treatment for EGFR-mutated lung cancer is evolving beyond the … in treating EGFR-mutated lung cancer,” Professor Ahn stated. … antibody-drug conjugates (ADCs), docetaxel ± ramucirumab combination therapy, …
About
© 1995-2025